Marcus Curley

Stock Analyst at UBS

(0.12)
# 4,257
Out of 4,345 analysts
181
Total ratings
37.6%
Success rate
-13.6%
Average return

Stocks Rated by Marcus Curley

Fisher & Paykel Healthcare Corporation Limited
May 27, 2026
Maintained: Hold
Price Target: n/a
Current: $37.91
Upside: -
The a2 Milk Company Limited
May 5, 2026
Maintained: Hold
Price Target: n/a
Current: $6.66
Upside: -
Synlait Milk Limited
Mar 24, 2026
Maintained: Sell
Price Target: n/a
Current: $0.44
Upside: -
EBOS Group Limited
Feb 26, 2026
Maintained: Buy
Price Target: n/a
Current: $19.55
Upside: -
SkyCity Entertainment Group Limited
Feb 19, 2026
Maintained: Hold
Price Target: n/a
Current: $0.505
Upside: -
Technology One Limited
Feb 18, 2026
Maintained: Buy
Price Target: $38.70
Current: $29.21
Upside: +32.49%
South32 Limited
Jan 14, 2026
Maintained: Hold
Price Target: $3.50
Current: $4.61
Upside: -24.00%
ResMed
Dec 12, 2025
Maintained: Buy
Price Target: $335$345
Current: $206.10
Upside: +67.39%
Ramsay Health Care Limited
Nov 16, 2025
Maintained: Hold
Price Target: $35.90
Current: $37.53
Upside: -4.34%
CSL Limited
Nov 6, 2025
Maintained: Buy
Price Target: $275.00
Current: $97.86
Upside: +181.03%
Maintained: Buy
Price Target: n/a
Current: $29.00
Upside: -
Downgraded: Sell
Price Target: n/a
Current: $0.45
Upside: -
Maintained: Buy
Price Target: $325.00$350.00
Current: $97.64
Upside: +258.46%
Maintained: Buy
Price Target: $36.00
Current: $13.18
Upside: n/a
Maintained: Hold
Price Target: $9.99
Current: $8.21
Upside: n/a
Maintained: Buy
Price Target: $1.85
Current: $2.29
Upside: n/a
Maintained: Buy
Price Target: $5.40
Current: $5.39
Upside: n/a
Upgraded: Buy
Price Target: n/a
Current: $3.11
Upside: n/a